Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The ACR gene encodes a sperm acrosome enzyme. Acrosin is a serine protein lyase(SP), located on the inner lining of the sperm head, is a membrane-bound enzyme. The acrosomal enzyme is mainly distributed on the inner membrane of the sperm acrosome and the equatorial membrane and is connected with the sperm acrosome membrane, which is essentially a trypsin-like serine protease. Mammalian fertilization is the process of combining sperm and egg. The sperm head has to pass through the zona pellucida. In addition to the morphological changes in the sperm head, it is more important that the acrosome reaction occurs. That is, the inactive acrosome zymogen is activated into an active acrosin and released, hydrolyzing the egg zona pellucida. Sperm vigorous movement and wedge-like action, smoothly through the cumulus and then through the zona pellucida to complete the fertilization process. In addition, acrosin also has the effect of increasing genital kinin release, enhancing sperm motility and promoting sperm motility. It can be seen that the acrosomal enzyme is a neutral protein hydrolase which is indispensable in the process of fertilization. The activity of the acrosome is largely determined by whether the fertilization process can proceed smoothly.
Mao et al. showed that the acrosome protein signal disappeared within 3 seconds after the acrosome reaction, while the signals of other acrosome components (eg, MN7 and MC41) remained for at least 15 minutes. The rapid disappearance of acrosome protein signals suggests that acrosomal enzymes may not participate in ZP (zona pellucida) penetration as previously thought. It is possible that early activation of acrosomal enzymes indicates a role prior to ZP infiltration.
Figure 1. Sperm–egg interaction. (Mao, et al. 2013)
Kim et al. showed that Acrosin Binding Protein (ACRBP) can be used to monitor normal spermatogenesis or in vitro germ cell development in testis tissue. Because ACRBP is present in the germ cells of a stalled stallion, it can be used as an indicator of stroma sexual maturity. Zhang et al. showed that semen superoxide dismutase (SOD) activity was significantly reduced in male infertile patients with positive antisperm antibodies (AsAb) compared to the normal fertility group. Similarly, sperm acrosome enzyme activity in AsAb-positive patients was also significantly reduced. This suggests that infertility caused by positive AsAb may be related to changes in semen SOD and sperm acrosome enzyme activity.
Factors Affecting Sperm Acrosin Activity
The clinical observation showed that the acrosome activity of the sperm at 1 to 5 days of abstinence was stable, but with the prolonged abstinence time, the acrosome activity decreased significantly after reaching 10 days. In addition, sperm acrosin activity has a certain correlation with sperm acrosome integrity rate and a significant positive correlation with the percentage of normal spermatozoa. This indicates that sperm turnover time in the body directly affects the fertilization process and is closely related to sperm acrosome enzyme activity.
The environment has a significant impact on conventional indicators such as sperm morphology and sperm count. With the deepening of the research, it was found that men who have been exposed to aromatic organic solvents or organochlorine insecticides for a long time have significantly reduced sperm motility and acrosin activity, and the extent of the decrease is closely related to the concentration and frequency of exposure. This suggests that these organic solvents may affect male fertility and accessory gonadal function.
Non-bacterial prostatitis (CAP IIIA) and chronic prostatitis (type IV prostatitis) can significantly reduce sperm acrosome enzyme activity, total sperm motility, sperm motility, normal morphological rate and sperm hypotonic swelling, but there was no significant effect on density and semen volume. Because these patients contain a large number of activated inflammatory cells in the prostatic fluid, they promote inflammation and on the other hand damage sperm by direct contact with sperm. On the other hand, the production of soluble substances by granulocytes increases the level of reactive oxygen species (ROS) in the seminal plasma and impairs sperm function.
Acrosin Inhibitor
The main functions of acrosin inhibitors are: First, to prevent premature release of sperm acrosin, damage to sperm to take action to protect the epithelial cells of the female reproductive tract during sperm and sperm transport. The second is to ensure the transparent band binding site and participate in sperm egg recognition. It may act through receptor molecules that bind to the surface of the sperm and become an important factor in stabilizing sperm-egg binding. That is, during the genital tract of the sperm in the mother, the binding site of the zona pellucida is exposed after the release of the inhibitor.
Human acrosome protease is an attractive target for the discovery of novel male contraceptives. Juntao et al. demonstrated that the isoxazole derivative ISO-1, a small molecule weak human acrosome enzyme inhibitor, was used as an optimized entry point. After two rounds of structure-based design inhibitors, a highly potent inhibitor of B6 (IC50 = 1.44 μM) was successfully confirmed. It shows better selectivity than trypsin and represents one of the most active human acrosome enzyme inhibitors to date.
Chen et al. showed that the four inhibitors designed showed effective acrosome inhibition activity. The scaffold of the compound was found to be important for the inhibitory activity. Several compounds are more active than the positive control TLCK, a previously reported acrosin small molecule inhibitor, suggesting that they can serve as a good starting point for the discovery of novel male contraceptives.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.